Serotonergic function in mothers of opioid addicts: Correlation with comorbid depression

Acta Psychiatrica Scandinavica

Volumn 96, Issue 1, 1997, Pages 36-42

  Gerra, G ^a,d   Caccavari, R ^a   Zaimovic, A ^a   Palladino, M ^a   Chittolini, B ^a   Giucastro, G ^a   Maestri, D ^b   Monica, C ^b   Fertonani Affini, G ^a   Delsignore, R ^b   Brambilla, F ^c  

^a Azienda Sanitaria Locale   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c Department of Rheumatology   (Italy)

^d Programma Dipendenze SerT   (Italy)

Author keywords

Cortisol; Depression; Heroin; Prolactin; Serotonin

Indexed keywords

DIAMORPHINE; FENFLURAMINE; HYDROCORTISONE; OPIATE; PROLACTIN; SEROTONIN AGONIST;

ADULT; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; HYDROCORTISONE RELEASE; MALE; MOTHER; OPIATE ADDICTION; PRIORITY JOURNAL; PROLACTIN RELEASE; SEROTONINERGIC SYSTEM;

EID: 8544277280     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1997.tb09902.x     Document Type: Article

References (27)

1. SCHUCKIT MA. Low level of response to alcohol as a predictor of future alcoholism. Am J Psychiatry 1994: 151: 184-189.
2. CADORET RJ, TROUGHTON E, O'GORMAN TW, HEYWOOD E. An adoption study of genetic and environmental factors in drug abuse. Arch Gen Psychiatry 1986: 43: 1131-1136.
3. CROUGHAN JL. The contributions of family studies to understanding drug abuse. In: ROBINS, LN ed. Studying drug abuse. New Brunswick, NJ: Rutgers University Press, 1988.
4. LUTHAR SS, ANTON SF, MERIKANGAS KR, ROUNSAVILLE BJ. Vulnerability to substance abuse and psychopathology among siblings of opioid abusers. J Nerv Ment Dis 1992: 180: 153-161.
5. ROUNSAVILLE BJ, KOSTEN TR, WEISSMAN MM. Psychiatric disorders in the relatives of probands with opiate addiction. Arch Gen Psychiatry 1991: 48: 33-42.
6. KHANTZIAN EJ. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry 1985: 142: 1259-1264.
7. GERRA G, FERTONANI G, TAGLIAVINI P et al. Serotonin function in detoxified heroin abusers: prolactin and cortisol response to the fenfluramine challenge, Psychiatr Res 1995: 58: 153-160.
8. COCORES JA. Co-addiction: a silent epidemic. Psychiatr Lett 1987: 5: 5-8.
9. BEATTIE M. Codependent no more. San Francisco: Harper & Row, 1987.
10. COCORES JA, GOLD MS. Sexual function in codependents. Hum Sexual 1989: 26: 24.
11. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, revised 4th edn. Washington, DC: American Psychiatric Press, 1994.
12. CERMAK TL. Diagnosing and treating co-dependence. Minnesota: Johnson Institute Books, 1986.
13. MORGAN JP JR. What is codependency? J Clin Psychol 1991: 47: 720-729.
14. ASHER R, BRISSETT D. Codependency: a view from women married to alcoholics. Int J Addict 1987: 23: 331-350.
15. CLARK J, STOFFEL VC. Assessment of codependency behaviour in two health student groups. Am J Occup Ther 1992: 46: 821-828.
16. PREZIOSI P, VACCA M, CERRITO F. Serotonergic and endogenous opiates interplay in the control of ACTH and prolactin release. Arch Intern Pharmacodyn Ther 1983: 263: 325-327.
17. LEWIS DA, SHERMAN BM. Serotonergic regulation of prolactin and growth hormone secretion in man. Acta Endocrinol 1985: 110: 152-157.
18. BROWN GL, GOODWIN FK. Aggression in humans correlates with cerebrospinal fluid amine metabolites. Psychiatr Res 1989: 1: 131-139.
19. COCCARO EF, LAWRENCE T, TRESTMAN R, GABRIEL S. KLAR HM, SIEVER LJ. Growth hormone responses to intravenous clonidine challenge correlate with behavioural irritability in psychiatric patients and healthy volunteers. Psychiatr Res 1991: 39: 129-139.
20. O'KEANE V, DINAN GT. Prolactin and cortisol responses to D-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function. Am J Psychiatry 1992: 148: 851-852.
21. BUSS AH, DURKEE A. An inventory for assessing different kinds of hostility. J Consult Psychology 1957: 21: 343-349.
22. DELGADO PL, CHARNEY DS. Neuroendocrine challenge tests in affective disorders: implications for future pathophysiological investigations. In: HORTON R, KATONA C, ed. Biological aspects of affective disorders. London: Academic Press, 1991: 145-190.
23. FISHBEIN DH, LOZOWSKY D, JAFFE JH. Impulsivity, aggression, and neuroendocrine responses to serotonergic stimulation in substance abusers. Biol Psychiatry 1989: 25: 1049-1067.
24. SIEVER LJ, KAHN RS, LAWLOR BA, TRESTMAN RL, LAWRENCE TL, COCCARO EF. Critical issues in defining the role of serotonin in psychiatric disorders. Pharmacol Rev 1991: 43: 509-525.
25. BROWN GL, EBERT MH, GOYER PF et al. Aggression, suicide, and serotonin: relationships to CSF amine metabolites. Am J Psychiatry 1982: 139: 741-746.
26. LINNOILA M, VIRKKUNEN M, SCHEININ M, NUUTILA A, RIMON R, GOODWIN FK. Low cerebrospinal fluid 5-hydroxyindolacetic acid concentration differentiates impulsive from nonimpulsive violent behaviour. Life Sci 1983: 33: 2609-2614.
27. GERRA G, CACCAVARI R, MARCATO A et al. Alpha-1 and 2-adrenoceptor subsensitivity in siblings of opioid addicts with personality disorders and depression. Acta Psychiatr Scand 1994: 90: 269-273.